Observational Study for Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease

This observational study is looking at people with rheumatoid arthritis (RA) to better understand interstitial lung disease (ILD), a condition where the lungs become scarred. Researchers want to identify what makes some RA patients more likely to develop ILD, and what factors cause it to get worse. They are looking for common features between RA-related ILD and other types of lung scarring. You may be able to join if you are 45 to 90 years old and have a diagnosis of RA. The study will look at the presence of ILD using special chest imaging (HRCT) after 3 to 5 years. The current recruitment status is unclear.

Study design
This is an observational study planning to enroll 750 participants. It is not testing a specific treatment.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 3 to 5 years to assess for interstitial lung disease on chest imaging.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT03297775

Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease

Recruiting
Not specifiedAges 45–90Observational
University of Colorado, Denver
~750 participants
Updated 2026-05-01 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Presence of interstitial lung disease on high resolution CT (HRCT) chest imaging
Measured over 3-5 years
Rheumatoid Arthritis
Interstitial Lung Disease
1 sites across 1 states
Colorado1
  • Joyce S Lee, MD · PRINCIPAL_INVESTIGATOR · University of Colorado, Denver

Opens a ready-to-send draft in your own email app — review before sending.

  • Presence of interstitial lung disease on high resolution CT (HRCT) chest imaging3-5 years

    HRCT scans of the chest will be interpreted by two radiologists and the presence or absence of interstitial lung abnormality will be recorded. When present, abnormalities will be categorized as absent, equivocal, non-fibrotic, or fibrotic, and the extent of any reticular abnormalities will be graded on an 11-point scale (0, 1-10%, 11-20%, etc.). Additionally, the presence or absence of airway disease, centrilobular thickening, mosaic attenuation, and air trapping will be recorded.